Pathkey.ai Limited has released a press release.
Opyl - Appendix 4E
Filed with ASX ·
On 6ix: 6ix.com/news/opyl-appendix-4e
6ix hasn’t read this filing yet.
Story so far
Earlier from Pathkey.AI
- Opyl Secures $700K loans to advance TrialKey & Drive Growth
- Opyl - Business Update & Appendix 4C
- OPL signs MOU for EMEA & US Expansion
- Opyl Partners with L39 Capital to Launch AI Biotech Fund
- Opyl Announces First Trial Gen Revenue & Customer
Later from Pathkey.AI
- Opyl - Full Year Results
- Opyl Enters Strategic Partnership with Alithia Life Sciences
- Strategic Partnership with Phenix Health Compendium Platform
- Opyl Signs New Service Agreement with Biointelect
- Opyl Signs New Service Agreement with Commercial Eyes
Follow Pathkey.AI into a list and get an email when it puts out news.
Follow Pathkey.AI